- Report
- July 2024
- 91 Pages
Global
From €3500EUR$4,210USD£3,162GBP
- Report
- July 2023
- 106 Pages
Global
From €3500EUR$4,210USD£3,162GBP
- Report
- January 2025
- 132 Pages
Global
From €846EUR$950USD£738GBP
- Report
- January 2025
- 132 Pages
Global
From €846EUR$950USD£738GBP
- Report
- March 2024
- 132 Pages
Global
From €846EUR$950USD£738GBP
- Report
- February 2024
- 132 Pages
Global
From €846EUR$950USD£738GBP
The Cytology market within the In Vitro Diagnostics (IVD) industry is focused on the diagnosis of diseases through the examination of cells. This includes the analysis of cells from body fluids, such as blood, urine, and sputum, as well as cells from tissue samples. Cytology tests are used to detect cancer, infections, and other diseases. The market is driven by the increasing prevalence of cancer and other chronic diseases, as well as the growing demand for early diagnosis and personalized treatments.
The Cytology market is highly competitive, with a range of products and services available from a variety of vendors. Companies in the market include Abbott, Becton Dickinson, Roche, Siemens, and Thermo Fisher Scientific. Show Less Read more